European Atherosclerosis Journal,
Год журнала:
2023,
Номер
2(1), С. 14 - 17
Опубликована: Апрель 30, 2023
The
VIII
Spring
Meeting
of
Young
Researchers
the
Italian
Society
Diabetology
(SID),
Arterial
Hypertension
(SIIA),
Internal
Medicine
(SIMI),
Cardiovascular
Prevention
(SIPREC)
and
for
Study
Atherosclerosis
(SISA)
“Basic
clinical
research:
Until
grant
let
us
apart”
was
held
in
Rimini
on
April
16-18,
2023.
As
is
customary,
Congress
organized
by
young
members
aforementioned
scientific
societies
operating
cardiometabolic
field.
featured
five
sessions
dedicated
to
discussion
recent
evidence
from
both
basic
researchers
treatment
prevention.
Many
had
opportunity
present
their
works
oral
poster
sessions.
In
this
report,
we
provided
a
summary
main
issues
discussed
during
lectures.
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(8), С. 7258 - 7258
Опубликована: Апрель 14, 2023
Alzheimer's
disease
(AD)
is
a
progressive
neurodegenerative
disorder
that
leads
to
dementia
and
patient
death.
AD
characterized
by
intracellular
neurofibrillary
tangles,
extracellular
amyloid
beta
(Aβ)
plaque
deposition,
neurodegeneration.
Diverse
alterations
have
been
associated
with
progression,
including
genetic
mutations,
neuroinflammation,
blood-brain
barrier
(BBB)
impairment,
mitochondrial
dysfunction,
oxidative
stress,
metal
ion
imbalance.Additionally,
recent
studies
shown
an
association
between
altered
heme
metabolism
AD.
Unfortunately,
decades
of
research
drug
development
not
produced
any
effective
treatments
for
Therefore,
understanding
the
cellular
molecular
mechanisms
underlying
pathology
identifying
potential
therapeutic
targets
are
crucial
development.
This
review
discusses
most
common
promising
discovery.
Furthermore,
it
highlights
role
in
summarizes
mathematical
models
AD,
stochastic
model
effect
Aβ
on
We
also
summarize
treatment
strategies
these
can
offer
clinical
trials.
World Journal of Diabetes,
Год журнала:
2024,
Номер
15(7), С. 1430 - 1447
Опубликована: Июль 8, 2024
Diabetes
mellitus
(DM)
and
Alzheimer's
disease
(AD)
are
two
major
health
concerns
that
have
seen
a
rising
prevalence
worldwide.
Recent
studies
indicated
possible
link
between
DM
an
increased
risk
of
developing
AD.
Insulin,
while
primarily
known
for
its
role
in
regulating
blood
sugar,
also
plays
vital
protecting
brain
functions.
Insulin
resistance
(IR),
especially
prevalent
type
2
diabetes,
is
believed
to
play
significant
AD's
development.
When
insulin
signalling
becomes
dysfunctional,
it
can
negatively
affect
various
functions,
making
individuals
more
susceptible
defining
features,
such
as
the
buildup
beta-amyloid
plaques
tau
protein
tangles.
Emerging
research
suggests
addressing
insulin-related
issues
might
help
reduce
or
even
reverse
changes
linked
This
review
aims
explore
rela-tionship
AD,
with
focus
on
IR.
It
explores
molecular
mechanisms
by
which
IR
lead
assesses
current
treatments
target
Understanding
IR's
connection
AD
offers
new
possibilities
highlights
importance
continued
this
interdisciplinary
field.
Alzheimer s Research & Therapy,
Год журнала:
2025,
Номер
17(1)
Опубликована: Янв. 7, 2025
Abstract
We
have
previously
demonstrated
that
the
intracellular,
non-GPI
anchored
CD59
isoforms
IRIS-1
and
IRIS-2
(Isoforms
Rescuing
Insulin
Secretion
1
2)
are
necessary
for
insulin
secretion
from
pancreatic
β-cells.
While
investigating
their
expression
across
human
tissues,
we
identified
mRNA
in
brain,
though
protein
function
remained
unclear.
This
study
shows
presence
of
both
2
proteins
specifically
neurons
astrocytes.
In
neuroblastoma
cell
line
(SH-SY5Y),
increases
upon
differentiation
into
mature
neurons.
Silencing
SH-SY5Y
cells
reduces
SNARE
complex
formation,
essential
synaptic
vesicle
exocytosis,
leading
to
a
reduction
noradrenaline
secretion.
Notably,
observed
diminished
neuronal
patients
with
Alzheimer’s
disease
(AD)
non-demented
individuals
type
diabetes
(T2D).
cells,
knockdown
all
including
not
only
elevates
phosphorylated
tau
but
also
cyclin-dependent
kinase
5
(CDK5)
expression,
known
promoter
hyperphosphorylation
accumulation
tau,
key
pathological
feature
AD.
Additionally,
found
prolonged
exposure
high
glucose
or
cytokines
markedly
suggesting
link
between
AD
pathology
metabolic
stress
through
modulation
these
isoforms.
Journal of Alzheimer s Disease,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 10, 2025
Background
Type
2
diabetes
mellitus
(T2D)
and
Alzheimer's
disease
(AD)
are
two
prevalent
chronic
diseases
that
pose
significant
global
health
challenges.
Increasing
evidence
suggests
a
complex
bidirectional
relationship
between
these
conditions,
where
T2D
elevates
the
risk
of
AD,
AD
exacerbates
glucose
metabolism
abnormalities
in
T2D.
Objective
This
review
explores
molecular
mechanisms
linking
focusing
on
role
insulin
signaling
pathways
oxidative
stress.
Methods
A
comprehensive
literature
search
from
PubMed,
Web
Science,
other
relevant
databases
was
conducted
analyzed.
Results
Insulin
resistance
leads
to
impaired
brain,
contributing
cognitive
decline
development
AD.
Hyperglycemia-induced
stress
neuronal
damage,
promoting
formation
amyloid-β
plaques
neurofibrillary
tangles
characteristic
Clinically
antidiabetic
drugs
such
as
metformin
show
potential
against
preclinical
studies;
Many
natural
products
Dendrobium
nobile
Lindl.
have
anti-T2D
efficacy
also
effective
various
vivo
vitro
models.
Conclusions
Improving
reducing
important
strategies
treatment
To
understand
bridging
singling
will
provide
insights
broader
applications
alleviating
Metabolites,
Год журнала:
2025,
Номер
15(3), С. 195 - 195
Опубликована: Март 11, 2025
Background/Objectives:
Ceramide,
a
sphingolipid
metabolite,
has
emerged
as
key
player
in
various
physiological
and
pathological
processes.
Changes
ceramide
levels
are
associated
with
the
occurrence
development
of
diseases,
highlighting
its
potential
biomarker
clinical
diseases.
Methods:
The
biosynthesis
metabolism
discussed,
along
functions
cell
signaling,
apoptosis,
inflammation.
This
study
further
examines
for
disease
diagnosis
treatment.
Results:
article
highlights
involvement
several
including
cardiovascular
dermatosis,
cancer,
neurodegenerative
disorders
metabolic
syndromes.
For
each
disease,
prognosis
is
explored,
feasibility
therapeutic
strategies
targeting
reviewed.
Additionally,
challenges
future
directions
field
research
addressed.
Conclusions:
review
provides
an
overview
recent
advances
understanding
role
diseases
diagnostic
tool.
European Journal of Pharmacology,
Год журнала:
2025,
Номер
unknown, С. 177510 - 177510
Опубликована: Март 1, 2025
Humanin
(HN)
is
an
endogenous
micropeptide
also
known
as
a
mitochondria-derived
peptide.
It
has
neuroprotective
effect
against
Alzheimer's
disease
(AD)
and
other
neurodegenerative
diseases
by
improving
hippocampal
acetylcholine
attenuating
the
development
of
oxidative
stress
associated
neurotoxicity.
HN
protects
neuron
from
toxic
effects
amyloid
beta
(Aβ).
regarded
biomarker
mitochondrial
stress.
Interestingly,
aging
reduces
brain
expression
HN,
leading
to
cognitive
impairment
elevating
risk
neurodegeneration,
including
AD.
However,
in
old
subjects
AD
patients,
circulating
levels
increase
compensatory
mechanism
reduce
neurodegeneration
dysfunction
Conversely,
studies
demonstrated
reduction
These
findings
indicated
controversial
points
regarding
precise
mechanistic
role
Therefore,
aim
this
review
was
discuss
exact
neuropathology
molecular
mechanisms
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
25(1), С. 108 - 108
Опубликована: Дек. 20, 2023
Diabetes
mellitus
is
a
chronic
metabolic
disease,
the
prevalence
of
which
constantly
increasing
worldwide.
It
often
burdened
by
disabling
comorbidities
that
reduce
quality
and
expectancy
life
affected
individuals.
The
traditional
complications
diabetes
are
generally
described
as
macrovascular
(e.g.,
coronary
heart
peripheral
arterial
stroke),
microvascular
diabetic
kidney
retinopathy,
neuropathy).
Recently,
due
to
advances
in
management
increased
patients,
strong
correlation
between
other
pathological
conditions
(such
liver
diseases,
cancer,
neurodegenerative
cognitive
impairments,
sleep
disorders)
has
emerged.
Therefore,
these
have
been
proposed
emerging
diabetes.
P66Shc
redox
protein
plays
role
oxidative
stress,
apoptosis,
glucose
metabolism,
cellular
aging.
can
be
regulated
various
stressful
stimuli
typical
milieu
involved
types
organ
tissue
damage
under
conditions.
Although
its
pathogenesis
remains
controversial,
there
evidence
regarding
involvement
p66Shc
In
this
review,
we
will
summarize
supporting
complications,
focusing
for
first
time
on
Foods,
Год журнала:
2024,
Номер
13(11), С. 1763 - 1763
Опубликована: Июнь 4, 2024
In
diabetes
mellitus,
disordered
glucose
and
lipid
metabolisms
precipitate
diverse
complications,
including
nonalcoholic
fatty
liver
disease,
contributing
to
a
rising
global
mortality
rate.
Theaflavins
(TFs)
can
improve
disorders
of
glycolipid
metabolism
in
diabetic
patients
reduce
various
types
damage,
glucotoxicity,
lipotoxicity,
other
associated
secondary
adverse
effects.
TFs
exert
effects
lower
blood
lipids
levels,
partly
by
regulating
digestive
enzyme
activities,
activation
OATP-MCT
pathway
increasing
secretion
incretins
such
as
GIP.
By
the
Ca2+-CaMKK
ꞵ-AMPK
PI3K-AKT
pathway,
promote
utilization
inhibit
endogenous
production.
Along
with
regulation
energy
AMPK-SIRT1
enhance
acids
oxidation
de
novo
lipogenesis.
As
such,
administration
holds
significant
promise
for
both
prevention
amelioration
mellitus.